GLS2 and systemic lupus erythematosus: In lupus-prone mice and SLE patients, GLS2 expression is reduced in CD4+ T cells, and GLS2 reduces ROS levels and promotes the ability of CD4+ T cells to produce IL-2 by demethylating the IL-2 gene (64).